Erste Enzymersatztherapie beim saure Sphingomyelinase-Mangel zugelassen
Crossref DOI link: https://doi.org/10.1007/s15014-023-4806-1
Published Online: 2023-02-15
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koczorek, Michael
Text and Data Mining valid from 2023-02-01
Version of Record valid from 2023-02-01
Article History
First Online: 15 February 2023
Free to read: This content has been made available to all.